Triostam in schistosomiasis
- 1 July 1954
- journal article
- research article
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 48 (4) , 351-352
- https://doi.org/10.1016/0035-9203(54)90109-1
Abstract
Most patients tolerate "triostam" (trivalent sodium antimonyl gluconate) satisfactorily in treatment of Schistosoma haematobium infections. A single course of 6 daily injns. of a 6% aqueous solution (total dose 20 mg/kg body wt.) given intraven. caused marked improvement in most patients and an apparent cure in 56%. Triostam is possibly preferable to sodium antimony tartrate, anthio-maline or nilodin for treatment of human schistosomiasis.Keywords
This publication has 0 references indexed in Scilit: